Novotrail Pharm Innovation Hub Profile
Key Indicators
- Authorised Capital ₹ 0.47 M
- Paid Up Capital ₹ 0.47 M
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2014
About Novotrail Pharm Innovation Hub
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73200MP2010PTC024273
-
Company No.
024273
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Sep 2010
-
Date of AGM
30 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Novotrail Pharm Innovation Hub?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vipin Gupta
![]() |
Managing Director | 08-Sep-2010 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Emmanuel Toppo
![]() |
Director | 01-Jun-2013 | Current |
Anurekha Jain
![]() |
Director | 08-Sep-2010 | Current |
Amit Talesara
![]() |
Director | 01-Jun-2013 | Current |
Financial Performance of Novotrail Pharm Innovation Hub.
Enhance accessibility to Novotrail Pharm Innovation Hub's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Novotrail Pharm Innovation Hub?
Unlock access to Novotrail Pharm Innovation Hub's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
![Placeholder for charges-related data](/Images/tcc-no-data-images/Charges.webp)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novotrail Pharm Innovation Hub?
Unlock and access historical data on people associated with Novotrail Pharm Innovation Hub, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Novotrail Pharm Innovation Hub, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novotrail Pharm Innovation Hub's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.